Loading clinical trials...
Loading clinical trials...
The primary objective is to compare the anti-tetanus neutralizing antibody titers of TNM002 Injection with human tetanus immunoglobulin (HTIG) following a single intramuscular (IM) injection in Chines...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Zhuhai Trinomab Pharmaceutical Co., Ltd.
NCT07107932 · Tetanus
NCT07203755 · Diphtheria, Tetanus and Acellular Pertussis, Epidemic Meningitis, and more
NCT07112144 · Prevent Whooping Cough, Prevent Diphtheria, and more
NCT06947499 · Diphtheria, Tetanus, and more
NCT06635798 · Tetanus
The First Affiliated Hospital of Shantou University Medical College
Shantou, Guangdong
Wuxi People's Hospital
Wuxi, Jiangsu
PKUCare Luzhong Hospital
Zibo, Shandong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions